12 completed, 5 terminated, 1 unknown, 1 withdrawn. 19 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 19 | Completed 12, Terminated 5, Unknown 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 4, Terminated 2, Withdrawn 1 |
Follow Interferon-gamma: new trials by email Literature Review of Interferon-gamma trials Research Report on Interferon-gamma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone - Asthma | Phase 1 | Terminated | Emory University | 1 | 2022-03-16 | 2025-06-03 |
| Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells - Acute Leukemia, Myelodysplastic Syndromes | Phase 1 | Terminated | Edwin Horwitz | 4 | 2021-12-02 | 2026-02-13 |
| Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Avelumab, Pembrolizumab - Other Skin | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 7 | 2019-07-03 | 2025-03-06 |
| Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer Interferon-gamma (IFN-γ), Paclitaxel, Trastuzumab - Breast Cancer, Breast Cancer, Male | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 51 | 2017-06-23 | 2023-04-19 |
| Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma Multiple drug microinjection, CIVO device - Soft Tissue Sarcoma Adult | Phase 1 | Completed | Presage Biosciences | 23 | 2016-12-15 | 2021-09-24 |
| Effect of IFN-γ on Innate Immune Cells Administration of drug (Interferon-gamma 1-b) subcutaneously - Chronic Granulomatous Disease | Phase 1 | Completed | University of Colorado, Denver | 20 | 2016-07-01 | 2019-02-15 |
| Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors interferon-gamma and nivolumab - Advanced Solid Tumors | Phase 1 | Completed | Fox Chase Cancer Center | 26 | 2015-12-11 | 2019-11-29 |
| DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors Single intratumoral injection of DNX-2401, Interferon-gamma - Glioblastoma or Gliosarcoma | Phase 1 | Completed | DNAtrix, Inc. | 37 | 2014-09-11 | 2018-07-16 |
| Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers interferon gamma 1b - Adverse Effects in the Therapeutic Use of Interferon | Phase 1 | Unknown | Vidara Therapeutics Research Ltd | 40 | 2013-07-01 | 2013-08-28 |
| The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma Interferon Gamma 1-b - Uveitis | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 2009-07-17 | 2017-07-02 |
| HGS-ETR2 to Treat Children With Solid Tumors Lexatumumab alone, Lexatumumab in combination, Interferon gamma 1b in combination - Ewing's Sarcoma, Osteosarcoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 30 | 2006-12-04 | 2019-12-17 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis Interferon-Gamma - HIV Coinfection, Aids/Hiv Problem | Phase 1 / Phase 2 | Completed | SPP Pharmaclon Ltd. | 78 | 2006-01-19 | 2024-01-25 |
| Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection Cytokine therapy, Interferon Gamma, GM-CSF - Mycobacterium Avium-Intracellulare Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2 | 2005-05-13 | 2017-07-02 |
| ITV Extension Study recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens, HIV gag-pol antigens and interferon-gamma (IFN-y) - HIV | Phase 1 / Phase 2 | Completed | Kirby Institute | 35 | 2002-09-01 | 2007-02-27 |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors recombinant interferon gamma - Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of Rochester | 1999-04-01 | 2013-06-06 | |
| Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer ALVAC-hB7.1, recombinant interferon gamma, laboratory biomarker analysis - Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 12 | 1997-10-01 | 2013-01-23 |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer fluorouracil, sodium phenylbutyrate, indomethacin - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 46 | 1997-05-01 | 2013-02-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia filgrastim, recombinant interferon gamma, busulfan - Leukemia | Phase 1 / Phase 2 | Withdrawn | Columbia University | 1996-02-01 | 2012-11-19 | |
| Biological Therapy in Treating Patients With Prostate Cancer aldesleukin, gene-modified tumor cell vaccine therapy, recombinant interferon gamma - Prostate Cancer | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 25 | 1995-01-01 | 2013-06-25 |
Neoplasm Metastasis (2) · Acquired Immunodeficiency Syndrome (1) · Asthma (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Ovarian Epithelial (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Colonic Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Graft vs Host Disease (1)
National Cancer Institute (NCI) (3) · Columbia University (1) · DNAtrix, Inc. (1) · Edwin Horwitz (1) · Emory University (1) · Fox Chase Cancer Center (1) · Fred Hutchinson Cancer Center (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Kirby Institute (1) · Memorial Sloan Kettering Cancer Center (1) · National Eye Institute (NEI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Presage Biosciences (1) · SPP Pharmaclon Ltd. (1) · University of Colorado, Denver (1)
United States (16) · Australia (1) · Russia (1)
Crystal L Mackall, M.D. (1) · Daniel R. Ambruso, MD (1) · David A Cooper, AO DSc MD FRACP FRCPA FRCP (1) · Edwin Horwitz, MD (1) · Edwin Horwitz, MD, PhD (1) · Frederick Lang, MD (1) · Gary Deutsch, MD (1) · Gwen L. Nichols, MD (1) · Joseph D. Rosenblatt, MD (1) · Joshua Veatch (1) · Karen Fink, MD, PhD (1) · Kenneth Gundle, MD (1) · Mark Matson, MD (1) · Matthew Zibelman, MD (1)
PMID 23071222, PMID 24576196, PMID 32299817, PMID 35113934, PMID 35880940, PMID 37500647, PMID 42715345
P01CA225517 (1), P30CA011198 (1), U01CA062461 (1), UL1TR001082 (1)